Document Detail


Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin.
MedLine Citation:
PMID:  8981116     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Several studies have shown that high concentrations of luteinizing hormone (LH) in the follicular phase of stimulation can have a negative effect on oocyte quality, pregnancy rate and incidence of miscarriage. The aim of the present study was to examine the effects of highly purified follicle stimulating/hormone (FSH HP) on ovarian stimulation and particularly on nuclear maturity and morphological appearance of the oocyte in intracytoplasmic sperm injection (ICSI) therapy and to compare the results with human menopausal gonadotrophin (HMG) stimulation. For this purpose, 50 patients for ICSI (HMG: 30; FSH HP: 20) and 26 patients for in-vitro fertilization (IVF; HMG: 14, FSH HP: 12) were stimulated with either HMG or FSH HP using a short-term protocol. Patients were divided into the two groups according to the first letter of their family name. No differences were observed among the groups in relation to patient age, duration of stimulation, number of aspirated oocytes or maturity of the oocyte-cumulus complex. After removal of the cumulus-corona cells in the ICSI oocytes, a significantly higher proportion of oocytes in the FSH HP group were nuclear mature (metaphase II) than in the HMG group (FSH HP: 88.8%, HMG: 80.6%; P = 0.009). Furthermore, in the FSH HP group, significantly fewer oocytes with dark cytoplasm were observed (FSH HP: 14.4%, HMG: 22.4%; P = 0.02). Fertilization, cleavage and pregnancy rates (FSH HP 38%, HMG: 34% per retrieval) were comparable in both groups. Based on the results obtained, it can be concluded that the short-term FSH HP treatment protocol synchronizes oocyte maturation better than comparable stimulation with HMG.
Authors:
B Imthurn; E Macas; M Rosselli; P J Keller
Related Documents :
9021366 - Intracytoplasmic sperm injection (icsi) for severe semen abnormalities: dissecting the ...
2508776 - In vitro fertilization and embryo transfer in the rhesus monkey.
15084486 - In vitro embryo production efficiency in cattle and its association with oocyte adenosi...
16209996 - Production of live offspring from mouse germinal vesicle-stage oocytes vitrified by a m...
21159046 - Stage i ovarian cancer cases during early, mid and late pregnancy periods: three case r...
15846196 - Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm pre...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  11     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  1996 Nov 
Date Detail:
Created Date:  1997-03-20     Completed Date:  1997-03-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  2387-91     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, University Hospital, Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Nucleus / drug effects*,  ultrastructure*
Cryopreservation
Embryo Transfer
Female
Fertilization in Vitro
Follicle Stimulating Hormone / pharmacology*,  therapeutic use
Humans
Menotropins / pharmacology*,  therapeutic use
Oocytes / drug effects*,  ultrastructure*
Pregnancy
Zygote / physiology
Chemical
Reg. No./Substance:
61489-71-2/Menotropins; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary sy...
Next Document:  Vasopressin and atrial natriuretic hormone response to hypertonic saline during the follicular and l...